Hyperthermia and Rigidity on an Inpatient Unit
Mr. K is a 27-year-old man with schizophrenia admitted four days ago for agitation and paranoia. He is receiving haloperidol 10 mg at night with up to 10 mg/day as needed; he received 25 mg total yesterday. He also takes benztropine 2 mg twice daily. Overnight he becomes mute, diaphoretic and rigid: temperature 39.1 °C, pulse 126, blood pressure 156/92, respirations 24. He is awake but not following commands, with lead-pipe rigidity in all limbs and bilateral cogwheeling. CK is 7,200 U/L, WBC 14.8, creatinine 1.5 mg/dL (baseline 0.9). He had a milder similar episode two years ago on risperidone. His mother asks whether this is 'just catatonia.'
1. How do you distinguish neuroleptic malignant syndrome from malignant catatonia and serotonin syndrome here, and what single piece of information most changes management?
Read the worked answer
Serotonin syndrome is unlikely. He has received no serotonergic agent, and serotonin syndrome typically produces clonus, hyperreflexia and dilated pupils rather than uniform lead-pipe rigidity with cogwheeling.
NMS is favored by the temporal link to a high-potency dopamine antagonist (25 mg haloperidol in 24 hours), hyperthermia, generalized rigidity, autonomic instability, leukocytosis, CK in the thousands, and a prior similar reaction to risperidone.
Malignant catatonia remains the main mimic and can be clinically indistinguishable. Features that would push me toward it are prior catatonic episodes, negativism, posturing, waxy flexibility, and stupor without a clear drug trigger.
The highest-yield 'test' is not a laboratory value but a careful medication timeline plus a structured examination for catatonic signs and a review of old records for the risperidone episode. A benzodiazepine challenge can support catatonia, but it must not delay cooling, hydration and stopping the antipsychotic. Creatinine rising from 0.9 to 1.5 signals rhabdomyolysis-associated kidney injury and dictates aggressive fluid resuscitation.
2. Outline your immediate management, including the role of dantrolene, bromocriptine, and ECT.
Read the worked answer
Immediately: stop haloperidol and benztropine, move to a monitored bed, cool with fans and cold IV fluids, give IV fluids targeting urine output of 1-2 mL/kg/hour, and recheck CK every 8-12 hours until it is clearly falling along with electrolytes, liver enzymes and coagulation studies.
Pharmacologic support: evidence is limited and neither agent is mandatory. Dantrolene 1-2.5 mg/kg IV every 6 hours addresses rigidity and heat production and is reasonable with severe rigidity or hyperthermia. Bromocriptine 2.5 mg orally three times daily, titrated, addresses the dopamine deficit and may help when rigidity dominates. Many patients improve with supportive care alone; do not let drug selection delay cooling and hydration.
ECT is indicated for refractory or life-threatening illness, for malignant catatonia, and when the picture is mixed or the patient deteriorates despite supportive care. It is often the most reliable treatment for the catatonic end of the spectrum.
Antipyretics alone do not work in NMS, and physical restraints can worsen hyperthermia and CK.
3. Twelve weeks later he is recovered and psychotic again. How do you approach antipsychotic rechallenge?
Read the worked answer
Rechallenge is possible but must be deliberate and consented. Before anything, confirm full resolution: afebrile for at least 48-72 hours, CK normalized, rigidity gone, and renal function back to baseline.
- Avoid high-potency typical agents and depot formulations, which are overrepresented in NMS reports.
- Consider clozapine given his treatment-resistant course; it carries a lower NMS risk, but it still requires weekly CBC monitoring and slow titration. If clozapine is chosen, the prior reaction is not an absolute bar.
- Alternatives include a low-potency atypical started at a fraction of the usual dose with 48-72 hours of close observation for rigidity, fever and mental status change, or a course of ECT if catatonia was prominent.
- Restart only when the team can monitor vitals and CK; avoid simultaneous PRN stacking of multiple antipsychotics, which likely contributed here.
- Educate the patient and family to report fever, stiffness or confusion immediately, and flag the allergy/reaction prominently in the chart so future clinicians do not repeat the exposure.